Dichotomous Toll-like receptor responses in chronic lymphocytic leukemia patients under ibrutinib treatment

Leukemia. 2019 Apr;33(4):1030-1051. doi: 10.1038/s41375-018-0335-2. Epub 2019 Jan 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Prognosis
  • Pyrazoles / pharmacology*
  • Pyrimidines / pharmacology*
  • Toll-Like Receptors / metabolism*

Substances

  • Pyrazoles
  • Pyrimidines
  • Toll-Like Receptors
  • ibrutinib